Search Results

Qosina, a global supplier of OEM single-use components to the medical and pharmaceutical industries, is pleased to announce a partnership with ILC Dover, a leader in the innovative design and production of solutions for biopharmaceutical, pharmaceutical and medical device markets.

ILC Dover LP, specializing in innovative single-use and chemical workflow solutions for biotherapeutics and pharmaceutical processing, announced plans to significantly expand production capabilities in its Juarez, Mexico facility.

ILC Dover, Inc. (“ILC Dover”, “ILC” or the “Company”), today announced the acquisition of KSE Scientific (“KSE”), a sterile solutions manufacturer which specializes in the production of Water for Injection (WFI) and related media and buffer solutions for biopharma, cell & gene therapy, tissue banking and medical device end-markets.

ILC Dover LP, specializing in the innovative design and production of single-use flexible solutions for global pharmaceutical and biopharmaceutical processing, introduced the soloPURE™ flexible aseptic isolator, a cost-effective, closed-barrier system for sterile manufacturing.

ILC Dover, Inc., a world leader in the design and production of single-use flexible solutions for pharmaceutical and biopharmaceutical manufacturing, announced the acquisition of Solo Containment, Ltd., a specialist manufacturer of flexible film isolators based in the United Kingdom.

ILC Dover, Inc. announced that it has partnered with New York-based New Mountain Capital, a leading growth-oriented investment firm with over $20 billion in assets under management.

ILC Dover, a world leader in the innovative design and production of engineered products employing high-performance flexible materials, announced that it expedited the regulatory approval and manufacturing processes of a new Powered Air Purifying Respirator hood for healthcare workers attending to patients with COVID-19.

Glympse to Present Two Posters Demonstrating Novel Protease Biosensor Diagnostic Platform Detection of Hepatocellular Carcinoma at EASL ILC 2022.

ClearB Therapeutics, Inc., a company developing CLB-3000, a therapeutic vaccine designed to drive a functional cure for Hepatitis B, announced today that two abstracts will be presented as posters at the European Association for the Study of the Liver (EASL) International Liver Congress (ILC) 2024, taking place in Milan, Italy 5 – 8 June 2024.

Dover Motion, with over 30 years of precision motion design and manufacturing expertise, announces the launch of their newest product: the SmartStage™ XY.